CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 5
  • ✓Age ≥18 years
  • ✓Proven HIV-1 infection
  • ✓On stable combination antiretroviral therapy (cART) with ≥3 registered agents for ≥3 years
  • ✓HIV-RNA <50 copies/mL throughout the 3 years prior to enrollment
Key exclusion· 2
  • ✕cART discontinuation between prior screening and study entry
  • ✕HIV-RNA >50 copies/mL between prior screening and study entry

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02972931
NCT02972931N/ACompleted
CompareCT.gov

Impact of Antiretroviral Treatment and Predictors in Subjects With Extremely Low HIV-1 Reservoir: Optimization of New Cure Strategies

IrsiCaixa·observational·Posted Nov 25, 2016·Updated Sep 19, 2024

In Brief

An observational study for Hiv. Completed, enrolled 62 participants across 1 site.

Detailed Summary

The main purpose of this study is to unravel the mechanisms by which the "Low Viral Reservoir Treated" patients (LoViReT) maintain extremely low HIV-1 DNA levels despite having initiated cART during chronic HIV-1 infection. This group may have specific and different clinical, virological and immunogenetical characteristics, compared to patients with regular reservoir size, which might be useful to design new and more effective treatment approaches.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHiv
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 25, 2016
Enrollment StartJan 18, 2018
Primary CompletionJun 20, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.6 years ago